Pre-Operative Single Shot Rectus Sheath Block

• Status: Unknown status
• Trial end date: 2020-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Objectives The primary objective is to demonstrate that in patients undergoing major urologic surgery, Patient Controlled Analgesia (PCA) opioid consumption in the first 24 hours after surgery will be significantly less in patients who have had a single shot rectus sheath block pre-operatively in addition to a post-operative rectus sheath continuous block via surgically placed catheter versus those who only have post-operative rectus sheath continuous block. Secondary outcomes will be opioid requirement intra-operatively, Numerical Rating Scale (NRS) pain scores including maximum pain score in Post Anesthesia Care Unit (PACU) and score at 24 and 48 hours, incidence and severity of nausea, number of vomiting episodes, sedation score, time to first bowel movement, time to first mobilization and duration of hospital stay.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Alberta
• Treatments: Analgesics, Opioid

Criteria

Inclusion Criteria:

• Adult patients over 18 years

• Undergoing major urological surgery

• Consent to a rectus sheath blockade as part of their postoperative management

Exclusion Criteria:

• Patients under 18 years

• Local or systemic infection

• Patients who refuse consent

• Opioid tolerance

• History of chronic pain

• Psychiatric illness

• Allergy to local anesthetic.